OP (4166.TWO) monthly revenue, September 2026
OP reported revenue of NT$0.15bn for September 2026, up 28.4% from the previous month and up 41.2% from a year earlier. Year-to-date revenue was NT$1.15bn, up 20.5% year on year. It ranked 28 of 159 companies in the Biotechnology and Medical Care industry by year-on-year growth.
| Month | Revenue NT$bn | MoM % | YoY % |
|---|---|---|---|
| September 2026 | 0.15 | 28.4 | 41.2 |